Cargando…
The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects
The aim of this study was to determine the changes of short chain fatty acids (SCFAs) in faeces of inflammatory bowel disease (IBD) patients compared to healthy subjects. SCFAs such as pyruvic, lactic, formic, acetic, propionic, isobutyric and butyric acids were analyzed by using high performance li...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887640/ https://www.ncbi.nlm.nih.gov/pubmed/20563285 http://dx.doi.org/10.2174/1874091X01004010053 |
_version_ | 1782182576111222784 |
---|---|
author | Huda-Faujan, N. Abdulamir, A.S. Fatimah, A.B. Anas, O. Muhammad Shuhaimi, M. Yazid, A.M. Loong, Y.Y. |
author_facet | Huda-Faujan, N. Abdulamir, A.S. Fatimah, A.B. Anas, O. Muhammad Shuhaimi, M. Yazid, A.M. Loong, Y.Y. |
author_sort | Huda-Faujan, N. |
collection | PubMed |
description | The aim of this study was to determine the changes of short chain fatty acids (SCFAs) in faeces of inflammatory bowel disease (IBD) patients compared to healthy subjects. SCFAs such as pyruvic, lactic, formic, acetic, propionic, isobutyric and butyric acids were analyzed by using high performance liquid chromatography (HPLC). This study showed that the level of acetic, 162.0 µmol/g wet faeces, butyric, 86.9 µmol/g wet faeces, and propionic acids, 65.6 µmol/g wet faeces, decreased remarkably in IBD faecal samples when compared with that of healthy individuals, 209.7, 176.0, and 93.3 µmol/g wet faeces respectively. On the contrary, lactic and pyruvic acids showed higher levels in faecal samples of IBD than in healthy subjects. In the context of butyric acid level, this study also found that the molar ratio of butyric acid was higher than propionic acid in both faecal samples. This might be due to the high intake of starch from rice among Malaysian population. It was concluded that the level of SCFAs differ remarkably between faecal samples in healthy subjects and that in IBD patients providing evidence that SCFAs more likely play an important role in the pathogenesis of IBD. |
format | Text |
id | pubmed-2887640 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-28876402010-06-18 The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects Huda-Faujan, N. Abdulamir, A.S. Fatimah, A.B. Anas, O. Muhammad Shuhaimi, M. Yazid, A.M. Loong, Y.Y. Open Biochem J Article The aim of this study was to determine the changes of short chain fatty acids (SCFAs) in faeces of inflammatory bowel disease (IBD) patients compared to healthy subjects. SCFAs such as pyruvic, lactic, formic, acetic, propionic, isobutyric and butyric acids were analyzed by using high performance liquid chromatography (HPLC). This study showed that the level of acetic, 162.0 µmol/g wet faeces, butyric, 86.9 µmol/g wet faeces, and propionic acids, 65.6 µmol/g wet faeces, decreased remarkably in IBD faecal samples when compared with that of healthy individuals, 209.7, 176.0, and 93.3 µmol/g wet faeces respectively. On the contrary, lactic and pyruvic acids showed higher levels in faecal samples of IBD than in healthy subjects. In the context of butyric acid level, this study also found that the molar ratio of butyric acid was higher than propionic acid in both faecal samples. This might be due to the high intake of starch from rice among Malaysian population. It was concluded that the level of SCFAs differ remarkably between faecal samples in healthy subjects and that in IBD patients providing evidence that SCFAs more likely play an important role in the pathogenesis of IBD. Bentham Open 2010-05-13 /pmc/articles/PMC2887640/ /pubmed/20563285 http://dx.doi.org/10.2174/1874091X01004010053 Text en © Huda-Faujan et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Huda-Faujan, N. Abdulamir, A.S. Fatimah, A.B. Anas, O. Muhammad Shuhaimi, M. Yazid, A.M. Loong, Y.Y. The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects |
title | The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects |
title_full | The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects |
title_fullStr | The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects |
title_full_unstemmed | The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects |
title_short | The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects |
title_sort | impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887640/ https://www.ncbi.nlm.nih.gov/pubmed/20563285 http://dx.doi.org/10.2174/1874091X01004010053 |
work_keys_str_mv | AT hudafaujann theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT abdulamiras theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT fatimahab theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT anasomuhammad theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT shuhaimim theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT yazidam theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT loongyy theimpactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT hudafaujann impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT abdulamiras impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT fatimahab impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT anasomuhammad impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT shuhaimim impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT yazidam impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects AT loongyy impactoftheleveloftheintestinalshortchainfattyacidsininflammatoryboweldiseasepatientsversushealthysubjects |